FARADAY PHARMACEUTICALS
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury. It has in-licensed proprietary liquid formulations of reduced nonmetal gaseous elements developed in the lab of Dr. Mark Roth at the Fred Hutchinson Cancer Center. The company was founded in 2014 and is located in Seattle, Washington.
FARADAY PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.faradaypharma.com
Total Employee:
1+
Status:
Active
Contact:
206-452-8700
Email Addresses:
[email protected]
Total Funding:
88 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail JsDelivr
Current Employees Featured
Founder
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Faraday Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series B - Faraday Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Faraday Pharmaceuticals
Washington Research Foundation
Washington Research Foundation investment in Series A - Faraday Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Faraday Pharmaceuticals
Washington Research Foundation
Washington Research Foundation investment in Series A - Faraday Pharmaceuticals
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series A - Faraday Pharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Faraday Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Faraday Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series A - Faraday Pharmaceuticals
Official Site Inspections
http://www.faradaypharma.com Semrush global rank: 5.11 M Semrush visits lastest month: 1.6 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Faraday Pharmaceuticals"
Leadership - Faraday Pharmaceuticals
Stephen A. Hill, BM BCh MA FRCS Faraday Pharmaceuticals. Steven Gillis, Ph.D. ARCH Venture Partners. Lawrence Gozlan Scientia CapitalSee details»
Our Story โ Faraday Pharmaceuticals
Faradayโs innovative approach to medicine stems from our beginnings. We are a clinical-stage biopharmaceutical company founded by Dr. Mark Roth of the โฆSee details»
Faraday Pharmaceuticals - Crunchbase Company โฆ
Contact Email [email protected] Phone Number 206-452-8700 Faraday Pharmaceuticals is an early-stage therapeutics company focused on โฆSee details»
Org Chart Faraday Pharmaceuticals - The Official Board
The organizational chart of Faraday Pharmaceuticals displays its 11 main executives including Stephen Hill, Brian Blackman and Shannon WilsonSee details»
Faraday Pharmaceuticals, Inc. | LinkedIn
Faraday Pharmaceuticals to Present at Oppenheimer & Co. Inc. 35th Annual Healthcare Life Sciences Conference See the full press release https://lnkd.in/grjkcSCa #faradaypharma #IocyteAMI3 #FDY_5301 13See details»
Faraday Pharmaceuticals, Inc. - SignalHire
Organization Website: faradaypharma.com : Social Links: Phone Number: 206-420-7312: Faraday Pharmaceutic... industries Pharma, Medical Research & Laboratories: Headquarters โฆSee details»
Leadership Team - The Org
About. The current leadership team at Faraday Pharmaceuticals has a wide range of experience in the pharmaceutical industry. The team includes a consultant, a Vice President, a Director, a โฆSee details»
Faraday Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Faraday Pharmaceuticals, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
Faraday Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Www.faradaypharma.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The โฆSee details»
Faraday Pharmaceuticals CEO and Key Executive Team - Craft
Faraday Pharmaceuticals's Director is Terry McGuire. Other executives include Stephen A. Hill, Chief Executive Officer, Director; Tressa Randall, Vice President Regulatory Affairs and 4 โฆSee details»
Faraday Pharmaceuticals - Products, Competitors, Financials, โฆ
The companyโs lead program, FDY-5301, is in a pivotal Phase 3 trial and is designed to reduce ischemia-reperfusion injury in acute STEMI, a leading cause of death and a primary cause of โฆSee details»
Faraday Pharmaceuticals Announces the Appointment of Dr.
Sep 3, 2015 Solvay was acquired by Abbott Labs in 2010. From 1999 to 2008, Dr. Hill served as President and CEO of ArQule where he successfully implemented the companyโs transition โฆSee details»
Faraday Pharmaceuticals - PitchBook
Faraday Pharmaceuticals General Information Description. Developer of novel therapeutics designed to offer elemental reducing agents. The company's therapeutics are focused on the โฆSee details»
Faraday Pharmaceuticals - Craft
Faraday Pharmaceuticals has 5 employees at their 1 location and $88 m in total funding,. See insights on Faraday Pharmaceuticals including office locations, competitors, revenue, โฆSee details»
Faraday Pharmaceuticals, Inc.๏ฝๆ่ณๅ ไผๆฅญ๏ฝUTEC-The University โฆ
Faraday Pharmaceuticals is focused on improving the quality of life for patients suffering from acute, critical illnesses. It was founded in 2014 based on the research of Dr. Mark Roth of the โฆSee details»
Pipeline โ Faraday Pharmaceuticals
Iocyte AMI-3 Phase 3 A Phase 3 randomized, double-blind, placebo-controlled, multicenter study of intravenous FDY-5301. Assessing the efficacy and safety of FDY-5301 in reducing the โฆSee details»
Overview, News & Similar companies - ZoomInfo.com
Dec 26, 2021 Faraday Pharmaceuticals contact info: Phone number: (206) 452-8700 Website: www.faradaypharma.com What does Faraday Pharmaceuticals do? Faraday โฆSee details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different โฆSee details»
Our Science โ Faraday Pharmaceuticals
FDY-5301โs unique properties are well-suited to mitigate ischemia-reperfusion injury (IRI). In preclinical IRI models FDY-5301, a formulation of sodium iodide, reduced tissue damage, โฆSee details»
PR โ Faraday Pharmaceuticals
Jul 16, 2024 Faraday Pharmaceuticals to Present at Oppenheimerโs 35th Annual Healthcare Life Sciences Conference. Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical โฆSee details»